Comparison of efficacy of low and high dose prophylactic platelet transfusion therapy in thrombocytopenic haemato-oncology patients
Open Access
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 59 (1) , 102610
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Transfusion‐related adverse events in the Platelet Dose studyTransfusion, 2014
- Dose of Prophylactic Platelet Transfusions and Prevention of HemorrhageNew England Journal of Medicine, 2010
- A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopeniaBlood, 2009
- The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) studyBlood, 2005
- Low‐dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian designTransfusion, 2004
- Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double‐blind trialTransfusion, 1999
- Apheresis platelets: Emerging issues related to donor platelet count, apheresis platelet yield, and platelet transfusion doseJournal of Clinical Apheresis, 1998
- Platelet Transfusion: A Dose-Response StudyBlood, 1998
- Mathematical modeling of platelet survival with implications for optimal transfusion practice in the chronically platelet transfusion‐dependent patientTransfusion, 1998